Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Phase 1/2 × B3(Fv)-PE38KDEL recombinant immunotoxin × 30 days × Clear all

Sponsor

Interventions

pembrolizumab 47 Carboplatin 36 Specimen Handling 34 Magnetic Resonance Spectroscopy 30 Biopsy 30 Cyclophosphamide 26 Nivolumab 20 Bevacizumab 19 venetoclax 18 fludarabine 18 Paclitaxel 18 Gemcitabine 18 Dexamethasone 18 Pemetrexed 17 Temozolomide 15 Cisplatin 14 Rituximab 13 Azacitidine 13 Prednisone 12 Lenalidomide 12 atezolizumab 11 Cetuximab 11 Vincristine 10 Fulvestrant 10 Irinotecan 9 fludarabine phosphate 8 durvalumab 8 X-Rays 8 Radiotherapy 8 Oxaliplatin 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡